Genomictree Market Cap

Genomictree has a market cap or net worth of 566.80 billion as of September 19, 2025. Its market cap has increased by 23.87% in one year.

Market Cap

566.80B

Enterprise Value

482.99B

Revenue

3.56B

Ranking

n/a

PE Ratio

n/a

Stock Price

23,600.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 566.80B, an increase of 860.70%. That is a compound annual growth rate of 30.65%.

Market Cap History

Date	Market Cap	% Change
Sep 19, 2025	566.80B	15.53%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	292.80B	-37.53%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.24T
Celltrion	37.12T
ALTEOGEN	25.30T
Yuhan	8,752.85B
SK Biopharmaceuticals	8,450.00B
Peptron	6,744.58B
PharmaResearch	6,316.91B
ABL Bio	5,473.88B

Market Cap Rankings